This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Michael Mills, CEO of the award-winning Body and Mind Inc. BAMM BMMJ joined Benzinga’s Cannabis Capital Conference on April 21, 2022 to discuss investments relating to multi-state operations in the production, cultivation and retail sale of high quality, medical and recreational cannabis products.
Body and Mind (BaM)’s wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses ever. The company’s products include its award-winning strain of cannabis flower, edibles, oils and extracts.
Watch the full presentation here:
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Image via BaM | Body and Mind on Instagram
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!